Cases & Deals

Sanofi sells anti-infective portfolio to ADVANZ PHARMA

Clients Sanofi

Jones Day advised Sanofi in the sale of a portfolio made up of eight anti-infectives including Azactam™, Cefotax™, Claforan™, Oroken™, Rulid™, Suprax™, Wintriaxone™ and Colistimethate Sodique products, which are critical in treating a broad range of infections, to ADVANZ PHARMA Corp. Limited, a UK-headquartered global pharmaceutical company with a strategic focus on specialty and hospital pharmaceuticals.